Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.22 USD | -6.54% | -10.04% | -24.14% |
May. 09 | Intellia Therapeutics' Q1 Net Loss Narrows, Collaboration Revenue Rises | MT |
May. 09 | Transcript : Intellia Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.14% | 2.4B | |
+51.41% | 63.85B | |
-2.26% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.40% | 26.52B | |
-21.49% | 18.69B | |
+2.76% | 12.73B | |
+21.60% | 12.11B | |
+27.84% | 12.07B |
- Stock Market
- Equities
- NTLA Stock
- News Intellia Therapeutics, Inc.
- Transcript : Intellia Therapeutics, Inc., Q4 2023 Earnings Call, Feb 22, 2024